Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Piperazine derivatives useful as CCR5 antagonists

US Patent 6689765 · Granted Feb 10, 2004

Estimated economic value: $44,502,000

Assignee

Inventors

View full patent text on Google Patents →